Sunwin Stevia International, Inc. engages in the manufacture and sale of natural sweetener, and herbs used in traditional Chinese medicines and veterinary products. It operates the business through the Stevioside and Chinese Medicine segments. The Stevioside segment produces and sells a variety of purified steviol glycosides with rebaudioside A and stevioside as the principal components, an all natural, low calorie sweetener, and OnlySweet, a stevioside based table top sweetener. The Chinese Medicine segment manufacture and sell traditional Chinese medicine formula extracts which are used in products made for use by both humans and animals. The company was founded on August 27, 1987 and is headquartered in Qufu, China.
Company profile
Ticker
SUWN
Exchange
Website
CEO
Dong Dong Lin
Employees
Location
Fiscal year end
Industry (SIC)
Former names
NETWORK USA INC, SUNWIN INTERNATIONAL NEUTRACEUTICALS, INC.
SEC CIK
Corporate docs
IRS number
562416925
SUWN stock data
Latest filings (excl ownership)
NT 10-K
Notice of late annual filing
22 Aug 23
8-K
Changes in Registrant's Certifying Accountant
9 Jun 23
NT 10-Q
Notice of late quarterly filing
17 Mar 23
10-Q
2023 Q2
Quarterly report
11 Jan 23
NT 10-Q
Notice of late quarterly filing
19 Dec 22
10-Q
2023 Q1
Quarterly report
19 Sep 22
NT 10-Q
Notice of late quarterly filing
14 Sep 22
10-K
2022 FY
Annual report
10 Aug 22
NT 10-K
Notice of late annual filing
29 Jul 22
10-Q
2022 Q3
Quarterly report
22 Apr 22
Latest ownership filings
Financial summary
Quarter (USD) | Oct 22 | Jul 22 | Apr 22 | Jan 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Apr 22 | Apr 21 | Apr 20 | Apr 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |